BRPI0811845A2 - Forma de dosagem, e, métodos de preparação da forma de dosagem, e de tratamento de uma má condição em um paciente - Google Patents

Forma de dosagem, e, métodos de preparação da forma de dosagem, e de tratamento de uma má condição em um paciente

Info

Publication number
BRPI0811845A2
BRPI0811845A2 BRPI0811845-0A2A BRPI0811845A BRPI0811845A2 BR PI0811845 A2 BRPI0811845 A2 BR PI0811845A2 BR PI0811845 A BRPI0811845 A BR PI0811845A BR PI0811845 A2 BRPI0811845 A2 BR PI0811845A2
Authority
BR
Brazil
Prior art keywords
dosage
patient
treatment
methods
bad condition
Prior art date
Application number
BRPI0811845-0A2A
Other languages
English (en)
Inventor
Zhen-Ping Wu
Richard Alexander Moore Jr
Original Assignee
Phenomix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenomix Corp filed Critical Phenomix Corp
Publication of BRPI0811845A2 publication Critical patent/BRPI0811845A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
BRPI0811845-0A2A 2007-05-21 2008-05-21 Forma de dosagem, e, métodos de preparação da forma de dosagem, e de tratamento de uma má condição em um paciente BRPI0811845A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93929207P 2007-05-21 2007-05-21
PCT/US2008/064363 WO2008144730A2 (en) 2007-05-21 2008-05-21 Stable pharmaceutical formulation for a dpp-iv inhibitor

Publications (1)

Publication Number Publication Date
BRPI0811845A2 true BRPI0811845A2 (pt) 2014-11-18

Family

ID=39651165

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811845-0A2A BRPI0811845A2 (pt) 2007-05-21 2008-05-21 Forma de dosagem, e, métodos de preparação da forma de dosagem, e de tratamento de uma má condição em um paciente

Country Status (7)

Country Link
US (1) US20100247642A1 (pt)
EP (1) EP2162119A2 (pt)
KR (1) KR20100020480A (pt)
BR (1) BRPI0811845A2 (pt)
CA (1) CA2688721A1 (pt)
MX (1) MX2009012619A (pt)
WO (1) WO2008144730A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
MX370599B (es) 2008-08-15 2019-12-18 Boehringer Ingelheim Int Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
TWI466672B (zh) 2009-01-29 2015-01-01 Boehringer Ingelheim Int 小兒科病人糖尿病之治療
NZ619520A (en) 2009-02-13 2015-06-26 Boehringer Ingelheim Int Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
NZ599298A (en) 2009-11-27 2014-11-28 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
EP2547339A1 (en) 2010-03-18 2013-01-23 Boehringer Ingelheim International GmbH Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions
WO2011138421A1 (en) 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy
NZ603319A (en) 2010-06-24 2015-04-24 Boehringer Ingelheim Int Diabetes therapy
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
JP2015527372A (ja) 2012-08-22 2015-09-17 ゼノポート，インコーポレイティド 副作用を低減させるモノメチルフマレートおよびそのプロドラッグの投与方法
US20140348915A9 (en) 2012-08-22 2014-11-27 Xenoport, Inc. Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
WO2014160633A1 (en) 2013-03-24 2014-10-02 Xenoport, Inc. Pharmaceutical compositions of dimethyl fumarate
TW201516020A (zh) 2013-09-06 2015-05-01 Xenoport Inc （ｎ，ｎ－二乙基胺甲醯基）甲基（２ｅ）丁－２－烯－１，４－二酸甲酯之晶形、合成方法及用途
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
US9930079B2 (en) 2014-07-18 2018-03-27 Facebook, Inc. Device-driven social network
US9967259B2 (en) * 2014-07-18 2018-05-08 Facebook, Inc. Controlling devices by social networking
CN104546476A (zh) * 2015-01-27 2015-04-29 石家庄正大鸿福牧业有限公司 一种兽用中药颗粒剂干法制粒方法
WO2023223164A1 (en) * 2022-05-17 2023-11-23 Pfizer Inc. Purification process for pharmaceutical excipient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI920206A0 (fi) * 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
US7317109B2 (en) * 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV

Also Published As

Publication number Publication date
CA2688721A1 (en) 2008-11-27
WO2008144730A2 (en) 2008-11-27
EP2162119A2 (en) 2010-03-17
KR20100020480A (ko) 2010-02-22
US20100247642A1 (en) 2010-09-30
WO2008144730A3 (en) 2010-01-21
MX2009012619A (es) 2010-02-12

Similar Documents

Publication Publication Date Title
PL2442814T3 (pl) Bifidobacteria do leczenia cukrzycy i pokrewnych chorób
PL2349388T3 (pl) Urządzenie i sposób do pozaustrojowej obróbki krwi
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
PL3318255T3 (pl) Kompozycje i sposoby leczenia udaru u pacjenta z jednoczesną terapią statyną
BRPI1014824A2 (pt) composição farmacêutica em forma de dose unitária e método de tratamento, prevenção ou redução da ocorrência de uma condição em um indivíduo
IL209887A0 (en) Treatment for diabetes in patients inappropriate for metformin therapy
BRPI1007636A2 (pt) Composição farmacêutica, forma de dosagem, método para a preparação da composição farmacêutica, método de preparação da forma de dosagem e método de tratamento da dor
BRPI0819642A2 (pt) Método para a formação de uma dentadura para um paciente em uma única visita, e, dentadura
NO2016023I1 (no) Glycerol fenylbutyrat
IL210755A0 (en) Devices and methods for forming tracts in tissue
EP2400916A4 (en) DENTAL AND MEDICAL TREATMENTS AND METHOD
IL214175A0 (en) Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
ZA201100210B (en) Pyridino-pyridinone derivatives,preparation thereof,and therapeutic use thereof
BRPI1008149A2 (pt) métodos para tratar uma ferida em um tecido, para aliviar uma infecção de tecido da cavidade oral, e, para branquear uma superfície de dente
BR112012016435A2 (pt) método para tratar desnutrição em um paciente de hemodiálise e composição aquosa estéril para administração parenteral
IL217198A0 (en) Composition for treating a patient in need of aspirin therapy
HRP20181877T1 (hr) Postupci za liječenje lijekovima koji uklanjaju amonijak
BRPI1015216A2 (pt) método de tratar ou prevenir uma condição médica em um indivíduo.
SI2341900T1 (sl) Medicinski proizvod in zdravljenje
EP2334304A4 (en) THERAPEUTIC BONE GROWTH AND BONE REGENERATION
BRPI0919670A2 (pt) composição, e, método para produzir uma composição, e para tratar um tumor em um paciente
IL218069A (en) Oligoscride compounds, drug, pharmaceutical, and compound for its use in therapy
IL216717A (en) Use of benzidamine in the manufacture of a drug for the treatment of p40-dependent diseases
FI20075861A0 (fi) Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä
EP2265206A4 (en) DETERMINING PATIENT-SPECIFIC STEAM TREATMENTS AND ADMINISTRATION PARAMETERS THEREFOR

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]